|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,196.00 INR | +0.18% |
|
-1.77% | +7.90% |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 07-22 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 620B 6.46B 5.68B 5.29B 4.86B 9.13B 9.25B 62.75B 24.56B 306B 24.26B 23.73B 1,058B | P/E 2026 |
44.2x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 580B 6.05B 5.32B 4.96B 4.55B 8.55B 8.66B 58.78B 23B 286B 22.72B 22.23B 991B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.49x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.18% | ||
| 1 week | -1.77% | ||
| Current month | -0.38% | ||
| 1 month | +1.93% | ||
| 3 months | -4.50% | ||
| 6 months | +11.60% | ||
| Current year | +7.90% |
| 1 week | 2,166 |  | 2,249.3 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Indrajit Bose
PSD | President | - | 14/09/2023 |
Ulhas Dhuppad
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.18% | -1.77% | +2.36% | +172.36% | 6.42B | |
| +1.68% | +2.13% | +16.17% | +77.49% | 48.36B | |
| +1.52% | +2.95% | +60.39% | +112.28% | 35.8B | |
| -0.09% | -0.66% | -8.03% | +31.90% | 11.83B | |
| -0.05% | -3.10% | +13.50% | +77.95% | 11.48B | |
| -0.37% | -0.37% | +37.53% | +142.08% | 9.01B | |
| +0.18% | +0.58% | +49.62% | -9.13% | 6.99B | |
| +0.95% | -2.00% | +12.78% | +32.58% | 6.7B | |
| +3.51% | -10.57% | -31.55% | +0.09% | 5.3B | |
| +0.49% | -0.97% | +21.61% | +124.86% | 4.37B | |
| Average | +0.80% | -1.23% | +17.44% | +76.25% | 14.63B | |
| Weighted average by Cap. | +1.10% | -0.18% | +25.41% | +82.91% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.4B 1.31B 1.2B 2.25B 2.28B 15.5B 6.07B 75.57B 5.99B 5.86B 261B | 167B 1.74B 1.53B 1.42B 1.31B 2.46B 2.49B 16.88B 6.61B 82.29B 6.53B 6.39B 285B |
| Net income | 20.53B 214M 188M 175M 161M 302M 306M 2.08B 814M 10.13B 804M 786M 35.06B | 23.28B 243M 213M 199M 183M 343M 347M 2.36B 923M 11.49B 911M 892M 39.76B |
| Net Debt | -39.29B -410M -360M -336M -308M -579M -586M -3.98B -1.56B -19.39B -1.54B -1.5B -67.1B | -37.12B -387M -340M -317M -291M -547M -554M -3.76B -1.47B -18.32B -1.45B -1.42B -63.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | ₹2,196.00 | +0.18% | 593,586 |
| 24/07/26 | ₹2,192.00 | -0.59% | 429,562 |
| 23/07/26 | ₹2,205.10 | +0.24% | 567,718 |
| 22/07/26 | ₹2,199.90 | -1.88% | 942,175 |
| 21/07/26 | ₹2,242.10 | +0.12% | 274,753 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
